BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23651481)

  • 1. p38 Mitogen-activated protein kinase inhibitors: a review on pharmacophore mapping and QSAR studies.
    Gangwal RP; Bhadauriya A; Damre MV; Dhoke GV; Sangamwar AT
    Curr Top Med Chem; 2013; 13(9):1015-35. PubMed ID: 23651481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p38 MAPK in cardioprotection - are we there yet?
    Martin ED; Bassi R; Marber MS
    Br J Pharmacol; 2015 Apr; 172(8):2101-13. PubMed ID: 25204838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships.
    Asquith CRM; East MP; Laitinen T; Alamillo-Ferrer C; Hartikainen E; Wells CI; Axtman AD; Drewry DH; Tizzard GJ; Poso A; Willson TM; Johnson GL
    Eur J Med Chem; 2024 May; 271():116357. PubMed ID: 38636130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational generation inhibitor-bound conformers of p38 MAP kinase and comparison with experiments.
    Bakan A; Bahar I
    Pac Symp Biocomput; 2011; ():181-92. PubMed ID: 21121046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease.
    Fisk M; Gajendragadkar PR; Mäki-Petäjä KM; Wilkinson IB; Cheriyan J
    Am J Cardiovasc Drugs; 2014 Jun; 14(3):155-65. PubMed ID: 24504769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer.
    Gupta J; Nebreda AR
    FEBS J; 2015 May; 282(10):1841-57. PubMed ID: 25728574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 MAP kinase inhibitors as anti inflammatory agents.
    Amir M; Somakala K; Ali S
    Mini Rev Med Chem; 2013 Dec; 13(14):2082-96. PubMed ID: 24107108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK-Activated Protein Kinases (MKs): Novel Insights and Challenges.
    Gaestel M
    Front Cell Dev Biol; 2015; 3():88. PubMed ID: 26779481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in kinase inhibition: treating rheumatic diseases and beyond.
    Gadina M
    Curr Opin Rheumatol; 2014 Mar; 26(2):237-43. PubMed ID: 24419749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 MAPK inhibitors: a patent review (2012 - 2013).
    Bühler S; Laufer SA
    Expert Opin Ther Pat; 2014 May; 24(5):535-54. PubMed ID: 24611721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of inhibitor selectivity in MAP kinases.
    Wang Z; Canagarajah BJ; Boehm JC; Kassisà S; Cobb MH; Young PR; Abdel-Meguid S; Adams JL; Goldsmith EJ
    Structure; 1998 Sep; 6(9):1117-28. PubMed ID: 9753691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the complete human-monkeypox virus interactome: Identifying immune responses and potential drug targets.
    Kataria R; Kaur S; Kaundal R
    Front Immunol; 2023; 14():1116988. PubMed ID: 37051239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinase inhibition in autoimmunity and inflammation.
    Zarrin AA; Bao K; Lupardus P; Vucic D
    Nat Rev Drug Discov; 2021 Jan; 20(1):39-63. PubMed ID: 33077936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host-Directed Antiviral Therapy.
    Kumar N; Sharma S; Kumar R; Tripathi BN; Barua S; Ly H; Rouse BT
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysophanol, Physcion, Hesperidin and Curcumin Modulate the Gene Expression of Pro-Inflammatory Mediators Induced by LPS in HepG2: In Silico and Molecular Studies.
    Selim NM; Elgazar AA; Abdel-Hamid NM; El-Magd MRA; Yasri A; Hefnawy HME; Sobeh M
    Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31484451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MAPK/MNK1 signaling in virus replication.
    Kumar R; Khandelwal N; Thachamvally R; Tripathi BN; Barua S; Kashyap SK; Maherchandani S; Kumar N
    Virus Res; 2018 Jul; 253():48-61. PubMed ID: 29864503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating ADME Properties by Fluorination: MK2 Inhibitors with Improved Oral Exposure.
    Velcicky J; Schlapbach A; Heng R; Revesz L; Pflieger D; Blum E; Hawtin S; Huppertz C; Feifel R; Hersperger R
    ACS Med Chem Lett; 2018 Apr; 9(4):392-396. PubMed ID: 29670707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efficacy and Underlying Mechanism of Moxibustion in Preventing Cognitive Impairment: A Systematic Review of Animal Studies.
    Choe S; Cai M; Jerng UM; Lee JH
    Exp Neurobiol; 2018 Feb; 27(1):1-15. PubMed ID: 29535565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR.
    Narayanan D; Gani OABSM; Gruber FXE; Engh RA
    J Cheminform; 2017 Jul; 9(1):43. PubMed ID: 29086093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin Stimulates Proliferation of Spinal Cord Neural Progenitor Cells via a Mitogen-Activated Protein Kinase Signaling Pathway.
    Son S; Kim KT; Cho DC; Kim HJ; Sung JK; Bae JS
    J Korean Neurosurg Soc; 2014 Jul; 56(1):1-4. PubMed ID: 25289117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.